relationship
live
diseas
agentsvirus
bacteria
fungi
parasitesand
human
anim
host
studi
differ
level
biologist
biochemist
analyz
relationship
molecular
cellular
level
constantli
make
advanc
knowledg
pathogenesi
infect
well
diagnosi
control
use
vaccin
medicin
clinician
play
lead
role
studi
applic
advanc
individu
cur
medicin
epidemiolog
studi
health
human
popul
scale
includ
transmiss
nontransmiss
diseas
also
consid
diseas
affect
anim
analys
factor
depend
agent
host
environ
come
play
popul
health
contribut
health
field
summar
follow
goal
collabor
clinic
laboratori
diagnosi
epidemiolog
function
defin
suspici
confirm
case
use
specif
laboratori
valid
techniqu
predict
appear
tendenc
infecti
noninfecti
diseas
epidemiolog
provid
record
inform
appropri
collect
sampl
impact
epidemiolog
describ
mortal
morbid
lifeyear
lost
death
disabl
paramet
measur
impact
differ
agent
also
predict
appear
tendenc
infecti
noninfecti
diseas
b
pathogeni
epidemiolog
analys
success
stage
diseas
consid
sourc
transmiss
mechan
portal
entri
human
dissemin
defens
mechan
elimin
commun
sever
indic
illustr
big
global
impact
acut
respiratori
infect
ari
public
health
morbid
mortal
accord
world
health
organ
respiratori
infecti
diseas
take
first
place
rank
burden
diseas
measur
year
lost
death
disabl
disabilityadjust
lifeyear
dali
lower
respiratori
tract
infect
repres
third
lead
caus
death
world
cardiac
encephal
vascular
ill
howev
countri
low
econom
statu
take
first
place
mani
region
global
estim
identifi
acut
respiratori
infect
primari
caus
ambulatori
consult
hospit
death
chile
take
second
place
third
place
lead
caus
death
children
adult
respect
furthermor
sever
studi
point
toward
main
caus
ambulatori
consult
absente
school
work
season
form
appear
high
infect
place
virus
respons
major
acut
respiratori
infect
accord
postneonat
mortal
estim
lower
respiratori
tract
infect
caus
death
respiratori
syncyti
viru
rsv
influenza
viru
common
advanc
viral
diagnosi
confirm
particip
virus
respiratori
pediatr
patholog
frequenc
go
compromis
lower
respiratori
tract
affect
upper
respiratori
tract
adult
scenario
upper
respiratori
tract
infect
similar
lower
respiratori
tract
infect
predomin
bacteri
etiolog
describ
howev
applic
molecular
viral
diagnosi
show
signific
particip
respiratori
virus
lower
respiratori
tract
infect
fact
acquir
relev
consid
age
popul
sever
virus
includ
group
respiratori
virus
respiratori
system
target
organ
nevertheless
virus
also
compromis
respiratori
system
system
infect
take
place
measl
chickenpox
enteroviru
hantaviru
especi
immunocompromis
individu
cytomegaloviru
herpesviru
shingl
furthermor
studi
alway
show
import
group
case
without
proven
etiolog
although
number
case
diminish
applic
molecular
diagnosi
techniqu
mani
potenti
pathogen
agent
detect
discov
tabl
clinic
manifest
viral
respiratori
diseas
vari
asymptomat
case
fatal
infect
sever
intermedi
scenario
virus
tend
produc
infect
mainli
upper
respiratori
tract
rhinoviru
coronaviru
adenoviru
other
similarli
compromis
lower
respiratori
airway
variabl
sever
adenoviru
rsv
metapneumoviru
influenza
parainfluenza
gener
accept
fact
respiratori
viru
compromis
one
sever
level
respiratori
system
caus
clinic
subclin
infect
certain
prefer
virus
compromis
specif
level
respiratori
system
tabl
way
epidem
viru
rsv
influenza
major
proport
upper
lower
respiratori
tract
infect
caus
preval
viru
addit
import
incid
subclin
infect
act
effici
sourc
transmiss
result
herd
immun
import
epidem
multipl
differ
virus
usual
coexist
commun
instead
altern
term
presenc
commun
exampl
chile
commonli
observ
pattern
involv
parainfluenza
outbreak
follow
influenza
outbreak
rsv
outbreak
later
winterspr
metapneumoviru
appear
thu
apex
epidem
follow
one
anoth
rare
overlap
unless
affect
popul
differ
age
phenomenon
viral
interfer
may
explain
gener
interferon
infect
patient
interfer
develop
infect
virus
circul
time
characterist
allow
us
suspect
specif
caus
outbreak
epidem
reason
certainti
consid
associ
clinic
case
detect
virus
sentinel
site
thu
winter
outbreak
involv
infant
year
old
caus
case
obstruct
bronchial
ill
due
rsv
characterist
trait
influenza
epidem
diseas
mark
fever
cough
headach
musculoskelet
ach
compromis
preschool
children
schoolchildren
young
adult
parainfluenza
viru
outbreak
associ
symptom
hoars
gruff
cough
besid
lower
respiratori
tract
infect
infant
adenovirus
fear
sometim
caus
intens
feverish
condit
sever
nosocomi
infect
epidemiolog
contribut
lot
clarifi
situat
alongsid
defin
suspici
case
implement
diagnost
system
circul
virus
fig
high
infect
virus
make
epidemiolog
inform
vital
import
etiolog
clinic
diagnosi
especi
term
contact
sick
patient
rel
close
peopl
commun
two
kind
respiratori
viru
greatest
impact
global
health
rsv
affect
infant
elderli
patient
influenza
b
compromis
popul
vaccin
viral
respiratori
infect
good
exampl
model
acut
viral
infect
virus
affect
individu
without
symptom
leav
within
period
day
week
cours
infect
depend
interact
variou
factor
depend
human
host
age
immun
statu
base
previou
infect
vaccin
activ
tobacco
use
etc
viru
infect
dose
type
serotyp
viral
strain
environ
season
weather
humid
contamin
geograph
locat
ruralurban
set
hospitalcommun
etc
host
standpoint
acut
respiratori
infect
frequent
childhood
particularli
infant
children
year
old
repres
group
biggest
seriou
risk
specif
diagnosi
respiratori
virus
quit
attain
nowaday
sever
immunodiagnost
techniqu
immunofluoresc
enzymelink
immunosorb
assay
elisa
immunochromatographi
avail
public
privat
center
easi
implement
reason
accept
sensit
specif
allow
appropri
studi
case
need
nowaday
molecular
techniqu
polymeras
chain
reaction
pcr
revers
transcript
pcr
also
avail
mani
laboratori
high
sensit
specif
provid
result
less
hour
great
sensit
techniqu
enabl
detect
mani
agent
even
sampl
rais
question
interpret
sever
case
deceas
patient
alway
implement
establish
caus
among
respiratori
virus
good
exampl
viral
emerg
found
classic
occurr
global
epidem
influenza
viru
deriv
bird
pig
occas
viru
broke
speci
barrier
thank
multipl
mutat
abl
transmit
effici
establish
human
viru
pandem
sever
acut
respiratori
syndrom
sar
due
coronaviru
anoth
exampl
phenomenon
threaten
world
abl
control
august
outbreak
lower
respiratori
tract
infect
children
associ
virus
certain
particular
requir
special
consider
tabl
process
describ
consid
popul
host
respiratori
virus
capabl
infect
human
divers
structuresrna
dna
nake
envelopedand
although
group
famili
great
varieti
serotyp
genotyp
strain
identifi
entail
exist
mani
differ
potenti
pathogen
sourc
infect
usual
anoth
human
carrier
viru
without
evid
clinic
infect
even
though
viral
shed
greater
symptomat
case
rel
isol
virus
suffer
host
rest
bed
make
viral
dissemin
less
effici
contrast
slight
subclin
case
despit
elimin
smaller
amount
viru
secret
patient
continu
normal
activ
activ
contribut
viral
diffus
mani
respiratori
infect
preschool
children
schoolchildren
main
dissemin
viru
satisfi
follow
two
condit
shed
high
viru
concentr
secret
regular
close
contact
schoolmat
rel
likewis
chanc
infect
anim
exist
hantaviru
cardiopulmonari
syndrom
sourc
viru
rodent
emerg
influenza
pandem
alway
repres
latent
threat
origin
avian
swine
virus
new
strain
abl
adapt
human
host
convert
viral
reservoir
also
coronavirus
usual
caus
upper
respiratori
tract
infect
repres
global
threat
emerg
anim
strain
acquir
charact
pandem
eg
sar
infect
mechan
work
respiratori
secret
elimin
big
particl
size
remain
hand
environ
apron
toy
medic
instrument
furnitur
small
particl
size
droplet
form
aerosol
stay
suspend
environ
sneez
cough
expel
secret
kmh
distanc
meter
virus
rhinoviru
rsv
contact
contamin
hand
repres
main
form
transmiss
upper
respiratori
mucosa
portal
entri
includ
ocular
conjunctiva
virus
also
repres
target
organ
viral
infect
dissemin
within
organ
happen
contigu
mucosa
contamin
secret
viru
diffus
due
proxim
infect
cell
healthi
cell
even
though
viru
escap
blood
territori
number
plu
symbol
list
viru
denot
rel
degre
respons
relev
syndrom
phase
viremia
essenti
pathogeni
infect
respiratori
viru
consid
local
infect
follow
pathogen
fact
explain
five
basic
clinic
epidemiolog
concept
share
respiratori
virus
incub
time
short
hour
day
abund
product
viru
portal
entri
facilit
viral
shed
high
infect
viral
diffus
via
mucos
proxim
caus
simultan
bilater
compromis
one
segment
respiratori
airway
annexesfor
exampl
paranas
sinus
middl
ear
defens
mechan
playboth
innat
specif
acquir
immunoglobulin
mainli
local
charact
specif
immun
temporari
last
month
tabl
prevent
viral
respiratori
infect
difficult
high
infect
favor
presenc
subclin
infect
human
sociabl
unavail
vaccin
except
influenza
viru
vaccin
treatment
fundament
symptomat
essenti
consist
mainten
permeabl
airway
oxygen
administr
assist
mechan
ventil
extrem
case
use
antiallerg
antiinflammatori
steroid
bronchodil
prophylact
antibiot
controversi
discuss
chapter
book
antivir
avail
influenza
virus
administr
earli
shorten
symptomat
period
seemingli
prevent
develop
seriou
ill
highrisk
patient
countri
temper
weather
incid
acut
respiratori
infect
increas
cold
season
appear
viral
epidem
rsv
viru
respons
usual
coincid
influenza
outbreak
addit
respiratori
adenovirus
appear
endem
unpredict
increas
acquir
relev
clinic
serious
propens
caus
inpati
infect
time
overload
hospit
despit
prevent
effici
fact
specif
treatment
respiratori
virus
health
care
public
privat
organ
prevent
sever
case
death
rsv
appear
winter
outbreak
last
month
estim
children
born
infect
first
year
life
children
contact
second
year
primari
infect
evolv
acut
lower
respiratori
tract
infect
requir
hospit
influenza
virus
usual
appear
autumn
epidem
last
week
accordingli
demand
pediatr
care
increas
everi
winter
emerg
rsv
domin
bed
directli
person
person
big
droplet
size
deposit
environ
secret
hand
cloth
furnitur
toy
small
droplet
size
form
aerosol
potenti
anim
sourc
influenza
viru
bird
pig
other
hantaviru
portal
entri
target
organ
short
incub
time
hour
day
high
infect
rate
commun
local
infect
local
defens
mechan
prevail
innat
immun
epitheli
barrier
cilia
cough
associ
lymphat
tissu
inflammatori
respons
leukocyt
macrophag
fever
cytokin
acquir
immun
local
immunoglobulin
gener
immunoglobulin
g
lymphocyt
type
type
helper
cell
shortdur
immun
frequent
reinfect
propag
proxim
individu
simultan
compromis
mani
level
respiratori
system
bilater
way
commun
affect
variou
member
close
contact
within
famili
school
work
hard
contain
isol
measur
physic
barrier
avail
infant
hospit
increas
need
ambulatori
care
influenza
virus
domin
consult
preschool
children
schoolchildren
adult
increas
demand
pediatr
ambulatori
hospit
care
forc
us
adopt
special
measur
manag
acut
lower
respiratori
tract
infectionsth
seriou
patholog
implement
ambulatori
hospit
level
object
winter
campaign
prevent
death
acut
lower
respiratori
tract
infect
direct
preferenti
toward
children
adult
greater
risk
develop
sever
ill
ambulatori
level
campaign
focus
two
aspect
educ
popul
recognit
seriou
symptom
longlast
fever
respiratori
distress
wheez
apnea
etc
encourag
earli
medic
consult
particularli
higherrisk
popul
preterm
infant
chronic
diseas
patient
immunosuppress
patient
gener
patient
month
age
increas
pediatr
ambulatori
care
includ
prolong
clinic
hour
afternoon
night
pediatr
kinesiotherapi
care
increas
avail
bronchodil
salbutamol
antimicrobi
medic
amoxicillin
implement
ambulatori
oximetri
oxygen
therapi
hospit
level
follow
measur
recommend
antiinfluenza
antipneumococc
vaccin
local
implement
rapid
diagnosi
rsv
influenza
adenoviru
use
immunofluoresc
elisa
reinforc
medic
paramed
emerg
medic
clinic
hospit
emerg
room
intens
care
unit
purpos
oper
room
repurpos
realign
attent
respiratori
case
equip
administr
oxygen
institut
convent
also
establish
facilit
transfer
sever
ill
patient
ensur
avail
cubicl
isol
individu
patient
admiss
case
suspect
confirm
adenoviru
chile
measur
appli
everi
year
sinc
great
success
reduc
death
though
morbid
decreas
depend
develop
vaccin
high
effect
fig
unlik
respiratori
infect
viral
caus
infect
bacteri
origin
frequent
affect
smaller
group
popul
given
characterist
term
pathogen
transmiss
prevent
measur
use
specif
vaccin
follow
section
discuss
epidemiolog
respiratori
infect
caus
streptococcu
pneumonia
bordetella
pertussi
pneumococcu
main
caus
bacteri
pneumonia
age
group
across
globe
incid
vari
accord
age
group
develop
statu
countri
employ
specif
vaccin
far
frequent
causal
agent
pneumonia
sinc
incid
pneumonia
caus
haemophilu
influenza
type
b
reduc
introduct
specif
vaccin
practic
made
infect
causal
agent
disappear
relev
risk
group
infant
year
old
adult
year
old
immunosuppress
patient
estim
agent
caus
death
one
million
peopl
everi
year
chile
know
reason
accuraci
epidemiolog
invas
pneumococc
infect
mening
septicemia
bacteremia
sinc
laboratori
monitor
nevertheless
great
major
pneumococc
pneumonia
bacterem
incid
pneumococc
pneumonia
unknown
data
extrapol
monitor
pneumonia
hospit
patient
assum
pneumococcu
primari
caus
bacteri
pneumonia
age
univers
vaccin
pneumococc
conjug
vaccin
introduc
incid
diseas
latin
america
patient
year
old
patient
year
old
subsequ
decreas
age
chile
vaccin
pneumococc
conjug
vaccin
introduc
children
born
sinc
novemb
rate
invas
infect
patient
year
old
decreas
approxim
although
impact
vaccin
age
group
contrari
increas
case
seen
among
patient
year
old
fig
preval
serotyp
prior
use
vaccin
last
postvaccin
period
serotyp
follow
serotyp
although
reduct
serotyp
sinc
introduct
vaccin
proport
serotyp
increas
age
group
serotyp
contain
vaccin
includ
one
suscept
penicillin
pneumococc
infect
emerg
topic
greatli
worri
clinician
although
manag
pneumonia
import
manag
pneumococc
mening
sinc
chang
cutoff
point
definit
resist
infect
outsid
central
nervou
system
suscept
penicillin
remain
low
resist
penicillin
greater
patient
year
old
age
group
topic
relev
pediatr
popul
recent
report
chilean
public
health
institut
show
rate
intermedi
sensit
penicillin
cefotaxim
preced
year
rate
resist
analyz
age
group
observ
patient
year
old
rate
intermedi
sensit
penicillin
cefotaxim
rate
resi
rev
chil
pediatr
tanc
antibiot
rate
resist
macrolid
age
group
reach
rate
suscept
levofloxacin
vancomycin
remain
b
pertussi
causal
agent
respiratori
infect
pose
seriou
risk
mortal
young
infant
especi
month
old
thank
introduct
vaccin
incid
mortal
rate
decreas
significantli
howev
despit
high
coverag
rate
vaccin
although
human
reservoir
b
pertussi
control
elimin
circul
yet
accomplish
distribut
ubiquit
million
case
death
annual
major
mortal
concentr
patient
year
old
particularli
month
old
chile
earli
sustain
increas
incid
start
regist
start
less
reach
new
increas
case
incid
rate
observ
incid
rate
vari
accord
age
group
reach
highest
rate
infant
month
old
drop
children
year
old
fig
case
patient
year
old
repres
notifi
case
month
old
featur
share
epidem
outbreak
mortal
concentr
young
infant
protect
primari
scheme
three
vaccin
dose
complet
child
month
age
sever
studi
sourc
infect
b
pertussi
young
infant
shown
main
sourc
intrafamili
contact
vaccin
lose
effect
year
vaccin
complet
adolesc
adult
infect
sinc
whoop
cough
alway
manifest
classic
clinic
case
adolesc
adult
rather
character
persist
cough
suspicion
level
low
appropri
diagnosi
often
made
thu
time
treatment
situat
facilit
infect
infant
within
famili
group
basi
epidemiolog
capullo
control
program
took
place
chile
entir
famili
group
newborn
vaccin
adolesc
eighth
grade
perform
incid
drop
less
aggreg
incid
reach
number
show
us
whoop
cough
diseas
affect
age
group
biggest
impact
term
morbid
mortal
patient
month
old
multipl
strategi
test
intern
none
effect
combin
differ
strategi
seem
key
systemat
perman
vaccin
pregnant
women
adolesc
famili
group
creation
vaccin
proven
high
efficaci
control
diseas
short
term
yet
accomplish
clinic
suspicion
import
appropri
treatment
case
adult
infant
reduc
risk
transmiss
former
reduc
mortal
latter
